Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EBITDA (2022 - 2025)

Historic EBITDA for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$14.3 million.

  • InflaRx's EBITDA rose 2544.93% to -$14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.1 million, marking a year-over-year increase of 6204.43%. This contributed to the annual value of -$49.8 million for FY2024, which is 878.46% down from last year.
  • Per InflaRx's latest filing, its EBITDA stood at -$14.3 million for Q3 2025, which was up 2544.93% from $16.4 million recorded in Q2 2025.
  • Over the past 5 years, InflaRx's EBITDA peaked at $16.4 million during Q2 2025, and registered a low of -$11914.8 billion during Q1 2023.
  • Moreover, its 4-year median value for EBITDA was -$10.5 million (2024), whereas its average is -$1036.6 billion.
  • As far as peak fluctuations go, InflaRx's EBITDA crashed by 8364227224.53% in 2023, and later skyrocketed by 9999.99% in 2024.
  • Over the past 4 years, InflaRx's EBITDA (Quarter) stood at -$14.1 million in 2022, then decreased by 20.73% to -$17.1 million in 2023, then skyrocketed by 68.81% to -$5.3 million in 2024, then plummeted by 169.58% to -$14.3 million in 2025.
  • Its last three reported values are -$14.3 million in Q3 2025, $16.4 million for Q2 2025, and -$8.9 million during Q1 2025.